Antimicrobial Peptides Past, Present and Future
International Journal of Nutrition and Food Sciences
Volume 5, Issue 6-1, December 2016, Pages: 1-4
Received: Jan. 5, 2016; Accepted: Jan. 6, 2016; Published: Oct. 18, 2016
Views 3970      Downloads 260
Authors
Yotova Maya, Medical Colledge, Medical University- Pleven, Pleven, Bulgaria
Kaloyanov Kaloyan, Department of Pharmacology, Pharmacotherapy and Toxicology, Faculty of Pharmacy, Medical University-Sofia, Sofia, Bulgaria
Petar Donchev, Department of Pharmacology, Pharmacotherapy and Toxicology, Faculty of Pharmacy, Medical University-Sofia, Sofia, Bulgaria
Zdraveva Petranka, Department of Pharmacognosy, Faculty of Pharmacy, Medical University-Sofia, Sofia, Bulgaria
Pencheva Ivanka, Department of Pharmaceutical chemistry, Faculty of Pharmacy, Medical University-Sofia, Sofia, Bulgaria
Article Tools
Follow on us
Abstract
Uncontrolled antibiotic use lead to increasing the level of resistant bacterial species. Antimicrobial peptides (AMPs) are one of the few alternatives in the fight with everyday growing bacterial resistance to commonly used antibiotics. AMPs general application could be also as endotoxin neutralizing agents or as an adjuvants to regular antimicrobial therapy. In this review we were focused on the most recent data that concern the diverse use of AMPs, their activities and modes of actions.
Keywords
Antimicrobial Peptides, Bacterial Resistance, Antibiotics
To cite this article
Yotova Maya, Kaloyanov Kaloyan, Petar Donchev, Zdraveva Petranka, Pencheva Ivanka, Antimicrobial Peptides Past, Present and Future, International Journal of Nutrition and Food Sciences. Special Issue: Analytical and Microbiological Characterization of Antimicrobial Peptides. Vol. 5, No. 6-1, 2016, pp. 1-4. doi: 10.11648/j.ijnfs.s.2016050601.11
Copyright
Copyright © 2016 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
References
[1]
European Centre for Disease Prevention and Control Antimicrobial Resistance Interactive Database (EARS-NET) data for 2013.
[2]
G. Y. Jerold, E. G. Romanowski and A. M. McDermott. “A Review of Antimicrobial Peptides and Their Therapeutic Potential as Anti-Infective Drugs.” Current eye research, vol.30, pp. 505–515, 2005. PMC. Web. 11 Dec. 2015.
[3]
N. Y. Yount and M. R. Yeaman. “Multidimensional signatures in antimicrobial peptides.” Proc Natl Acad Sci USA. Vol. 101, pp. 7363–7368, 2004.
[4]
M. Zasloff. “Antimicrobial peptides of multicellular organisms.” Nature. Vol. 415, pp. 389–395, 2002.
[5]
H. M. Lamb, and L. R. Wiseman. Pexiganan acetate. Drugs. Vol. 56, pp. 1047–1052. discussion 1053–1044, 1998.
[6]
http://www.dipexiumpharmaceuticals.com/locilex/clinical-trials.
[7]
Iseganan Hydrochloride in Preventing Oral Mucositis in Patients Who Are Undergoing Radiation Therapy for Head and Neck Cancer. https://clinicaltrials.gov/ ct2/show/NCT00022373.
[8]
H. Choi and D. G. Lee. “Synergistic effect of antimicrobial peptide arenicin-1 in combination with antibiotics against pathogenic bacteria.” Res Microbiol. Vol. 163(6-7), pp. 479-86, July 2012. doi: 10.1016/j.resmic.2012.06.001. Epub 2012 Jun 15.
[9]
J. M. Kahlenberg and M. J. Kaplan, “Little Peptide, Big Effects: The Role of LL-37 in Inflammation and Autoimmune Disease.” J. immunol. Vol. 191, pp. 4895-4901, November 2013; doi: 10.4049/jimmunol.1302005.
[10]
W. A. Lynn, “Anti-endotoxin therapeutic options for the treatment of sepsis.” J. Antimicrob. Chemother. Vol. 41, pp. 71-80, 1998; doi: 10.1093/jac/41.suppl_1.71.
[11]
J. C. Hurley. “Towards Clinical Applications of Anti-endotoxin Antibodies; A Re-appraisal of the Disconnect.” Toxins. vol. 5(12), pp. 2589–2620, 2013 http://doi.org/10.3390/toxins5122589.
[12]
L. Xu, S. Chou, J. Wang, C. Shao, W. Li, X. Zhu and A. Shan, “Antimicrobial activity and membrane-active mechanism of tryptophan zipper-like β-hairpin antimicrobial peptides.” Amino Acids. Vol. 47, pp. 2385-2397, November 2015. DOI: 10.1007/s00726-015-2029-7.
[13]
B. J. Dong, Z. G. Zhan, R. Q. Zheng, W. Chen and J. J. Min, “CDNA cloning and functional characterisation of four antimicrobial peptides from Paa spinosa.” Z Naturforsch C. Vol. 70(9), pp. 251-256, September 2015; DOI: 10.1515/znc-2015-4220.
[14]
Y. Liu, J. Eichler and M. Pischetsrieder, “Virtual screening of a milk peptide database for the identification of food-derived antimicrobial peptides” Mol Nutr Food Res, vol. 59, pp. 2243-2254, July 2015; DOI: 10.1002/mnfr.201500182.
[15]
C. Cézard, V. Silva-Pires, C. Mullié and P. Sonnet, Antibacterial Peptides: A Review in Science against microbial pathogens: communicating current research and technological advances, A. Méndez-Vilas (Ed.), pp. 926–937, ©FORMATEX 2011.
[16]
A. P. Gomes, J. F. Mano, J. A. Queiroz and I. C. Gouveia. “Incorporation of antimicrobial peptides on functionalized cotton gauzes for medical applications.” Carbohydr Polym, vol.127, pp. 451-461, August 2015. DOI: 10.1016/j.carbpol.2015.03.089.
[17]
R. J. Blower, S. M. Barksdale and M. L. van Hoek. “Snake Cathelicidin NA-CATH and Smaller Helical Antimicrobial Peptides Are Effective against Burkholderia thailandensis.” PLoS Negl Trop Dis, Vol. 9, pp. e0003862, July 2015.
[18]
G. Rajasekaran, R. Kamalakannan and S. Y. Shin. “Enhancement of the anti-inflammatory activity of temporin-1Tl-derived antimicrobial peptides by tryptophan, arginine and lysine substitutions.” J. Pept. Sci., Vol. 21, pp. 779-785, August 2015; DOI: 10.1002/psc.2807.
[19]
C. F. Le, M. Y. Yusof, H. Hassan and S. D. Sekaran. “In vitro properties of designed antimicrobial peptides that exhibit potent antipneumococcal activity and produces synergism in combination with penicillin.” Sci. Rep., Vol. 5, pp. 9761. May 2015; DOI: 10.1038/srep09761.
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186